|Articles|July 1, 2007
- Volume 0 0
Update on Investigational Alzheimer's Drug
Author(s)Susan Farley
Advertisement
Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.
The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.
Articles in this issue
over 18 years ago
pharmacy TECHNOLOGY newsover 18 years ago
pharmacy TECHNOLOGY productsover 18 years ago
health-systems PRODUCT newsover 18 years ago
generic times product newsover 18 years ago
can you READ these Rxs?over 18 years ago
A closer look at new FDA actionsover 18 years ago
can you READ these Rxs?over 18 years ago
compounding HOTLINEover 18 years ago
Is There Science in Quality?over 18 years ago
Vaccines: Are You Protected?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5